Boston Scientific BSX Revenue Breakdown

NYSE BSX
$43.00 -0.66 (-1.51%)
At close: Nov 19, 2026 · 4:00 PM EST
Quarterly revenue breakdowns for Boston Scientific, quarters ended Mar 2013 to Sep 2026, as reported in its filings.
Quarterly history

Boston Scientific Quarterly Revenue by Product & Service

Quarters Mar 2017–Sep 2026
Lines 8
Sep 2026 Total $5.14B

Interventional Cardiology & Vascular Therapies was Boston Scientific’s largest product and service line in the Sep 2026 quarter, bringing in $1.27B of $5.14B (25%).

Boston Scientific revenue by product and service, quarters ended Mar 2017 to Sep 2026
Product and Service Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Mar 2026 Jun 2026 Sep 2026
Interventional Cardiology & Vascular Therapies $1.24B $1.33B $1.27B
Endoscopy $736.00M $793.00M $741.00M
Cardiac Rhythm Management $578.00M $585.00M $568.00M
Urology $646.00M $684.00M $661.00M
Electrophysiology $905.00M $916.00M $816.00M
Watchman $506.00M $507.00M $482.00M
Interventional Oncology & Embolization $268.00M $283.00M $267.00M
Neuromodulation $318.00M $341.00M $331.00M
Total $5.20B $5.44B $5.14B
Totals include 13 discontinued lines from earlier reporting.
Quarterly history

Boston Scientific Quarterly Revenue by Segment

Quarters Mar 2013–Sep 2026
Lines 2
Sep 2026 Total $5.14B

Cardiovascular was Boston Scientific’s largest segment in the Sep 2026 quarter, bringing in $3.41B of $5.14B (66%).

Boston Scientific revenue by segment, quarters ended Mar 2013 to Sep 2026
Segment Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015 Jun 2015 Sep 2015 Dec 2015 Mar 2016 Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Cardiovascular $3.48B $3.50B $3.62B $3.41B
Medsurg $1.81B $1.70B $1.82B $1.73B
Total $5.29B $5.20B $5.44B $5.14B
Totals include 11 discontinued lines from earlier reporting.
Quarterly history

Boston Scientific Quarterly Revenue by Geography

Quarters Mar 2017–Sep 2026
Lines 2
Sep 2026 Total $5.14B

U.S was Boston Scientific’s largest region in the Sep 2026 quarter, bringing in $3.31B of $5.14B (64%).

Boston Scientific revenue by geography, quarters ended Mar 2017 to Sep 2026
Geography Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
U.S $3.39B $3.28B $3.43B $3.31B
Int'L $1.90B $1.92B $2.02B $1.83B
Total $5.29B $5.20B $5.44B $5.14B
Totals include 7 discontinued lines from earlier reporting.

Boston Scientific Revenue Breakdown API

Pull Boston Scientific's revenue breakdown - every line it reports, for every period - into your own models, spreadsheets and apps with the Business Quant Segments API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/segments?series=Revenue&ticker=BSX&dimension=Quarter&api_key=YOUR_API_KEY